Saturday, October 3, 2026

EUR/CHF Slides By 1% In The Last 21 Sessions

ViaNews Editorial Team

December 5, 2023

EUR/CHF Slides By 1% In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.96% for the last 21 sessions. At 01:06 EST on Tuesday, 5 December, EUR/CHF (EURCHF) is $0.95.

EUR/CHF's yearly highs and lows, it's 0.457% up from its 52-week low and 6.309% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.33%, a negative 0.04%, and a positive 0.24%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.36% (last week), 0.21% (last month), and 0.24% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd forex signal: hammer candlestick points to more upside - 04 December 2023. According to DailyForex on Monday, 4 December, "Forex Brokers We Recommend in Your Region See full brokers list 1 Read full review Get Started BrokerGeoLists.push({type:'ReviewsNonPartner',id:'horizontal-top-5',size:5,fullReviewText:`Read full review`,getStartedText:`Get Started`,readReviewText:`Review`});Bullish viewBuy the EUR/USD pair and set a take-profit at 1.0925.", "The EUR/USD pair crashed hard after a statement by Powell who warned against complacency among market participants. "
  • According to FXStreet on Monday, 4 December, "The Euro (EUR) remains under selling pressure against the US Dollar (USD) on Monday, motivating EUR/USD to revisit the mid-1.0800s at the beginning of a new trading week.", "If the EUR/USD continues to experience further losses, it could potentially face the mentioned200-day SMAas an initial point of support. "
  • Eur/usd price analysis: loses ground below 1.0900, further downside cannot be ruled out. According to FXStreet on Monday, 4 December, " According to the four-hour chart, the bullish outlook of EUR/USD looks vulnerable as the major pair hovers around the key 100-hour Exponential Moving Averages (EMA). "
  • Eur/usd holds below 1.0900, focus on German trade balance, ecb’s lagarde speech. According to FXStreet on Monday, 4 December, "The EUR/USD pair snaps its three-day losing streak during the early Asian trading hours on Monday. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com